CALZF (CALZF) Stock Price & Analysis
CALZF (CALZF) rose 0.00% to USD 0.8 as of June 10, 2026 at 04:10 UTC, according to Nexqual real-time market data.
CALZF last closed at USD 0.8; the session ranged USD 0.6–0.6 on volume of 19,538 shares. Market capitalization is $549.63M, with a 52-week range of USD 0.55–1.02 (PNK). Source: Nexqual, June 10, 2026 at 04:10 UTC.
Key Statistics (as of June 10, 2026 at 04:10 UTC)
| Price | USD 0.8 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.8 |
| Open | USD 0.6 |
| Day Range | USD 0.6 – 0.6 |
| 52-Week Range | USD 0.55 – 1.02 |
| Volume | 19,538 shares |
| Market Cap | $549.63M |
| Exchange | PNK |
Technical Analysis (CALZF)
Nexqual's technical model rates CALZF "BUY" based on 4 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 04:10 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 50.59 (neutral) |
| vs SMA50 | Above (USD 0.73) |
| MACD | 0.02 (positive) |
Analyst Ratings (CALZF)
Wall Street analysts rate CALZF "None", per Nexqual as of June 10, 2026 at 04:10 UTC.
| Consensus Rating | None |
|---|
Earnings (CALZF)
Source: Nexqual, June 10, 2026 at 04:10 UTC.
Financials & Fundamentals (CALZF)
| Total Revenue | $139.49M |
|---|---|
| Revenue Growth (YoY) | +18.10% |
| Gross Margin | +87.43% |
| Operating Margin | +3.00% |
| Profit Margin | +7.08% |
| ROE | +12.46% |
| Debt / Equity | 21.88 |
| Current Ratio | 3.04 |
| Total Cash | $29.26M |
| Total Debt | $18.19M |
| Free Cash Flow | $-6.94M |
Source: Nexqual, June 10, 2026 at 04:10 UTC.
Financial Health Score (CALZF)
Nexqual rates CALZF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 04:10 UTC.
| Growth | Strong — Revenue +23% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 87%, operating 3% |
| Balance Sheet | Strong — $29M cash vs $18M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$7M, burning cash |
| Efficiency | Mixed — ROE 12%, ROA 2.3% |
Ownership (CALZF)
| Insider Ownership | +11.03% |
|---|---|
| Institutional Ownership | +34.25% |
| Shares Outstanding | 690.84M |
| Float | 616.76M |
Source: Nexqual, June 10, 2026 at 04:10 UTC.
Leadership (CALZF)
CALZF is led by Bruce Peatey, Chief Executive Officer, per Nexqual as of June 10, 2026 at 04:10 UTC.
| Chief Executive Officer | Bruce Peatey |
|---|---|
| CFO & Company Secretary | Jan-Marcel Gielen C.A. |
| Chief Scientific Officer | Marthe D'Ombrain |
| President of North America | Edward Graubart |
Major Backers & Investors (CALZF)
Notable institutional backers of CALZF include -Polar Capital International Small Company Fund, Charles Schwab, according to Nexqual as of June 10, 2026 at 04:10 UTC.
Active Investors
| Investor | Stake |
|---|---|
| -Polar Capital International Small Company Fund | 0.27% |
| Charles Schwab | 0.19% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.55% |
| BlackRock | 1.25% |
| State Street | 0.25% |
Source: Nexqual, June 10, 2026 at 04:10 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PTCHF | PureTech Health PLC | USD 1.8 | ▼ 3.33% |
| PHGUF | Pharming Group NV | USD 1.18 | ▲ 0% |
| CVALF | Covalon Technologies Ltd. | USD 1.52 | ▲ 0% |
| MEOBF | Mesoblast Ltd. | USD 1.7 | ▲ 0% |
| SLNCF | Silence Therapeutics, Plc. | USD 1.06 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:10 UTC. This page is informational and not investment advice.